Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX2TFK
|
||||
Drug Name |
1-[4-(3,5-Dibromo-8-chloro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)-piperidin-1-yl]-2-(1-oxy-pyridin-4-yl)-ethanone
|
||||
Synonyms |
CHEMBL416231
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C26H22Br2ClN3O2
|
||||
Canonical SMILES |
[O-][n+]1ccc(CC(=O)N2CCC(CC2)C3c4ccc(Cl)cc4C=C(Br)c5cc(Br)cnc35)cc1
|
||||
InChI |
InChI=1S/C26H22Br2ClN3O2/c27-19-14-22-23(28)13-18-12-20(29)1-2-21(18)25(26(22)30-15-19)17-5-7-31(8-6-17)24(33)11-16-3-9-32(34)10-4-16/h1-4,9-10,12-15,17,25H,5-8,11H2
|
||||
InChIKey |
GJOYCZXIAXQQNR-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.